These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24005637)

  • 1. [Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].
    Burcelin R; Chabo C; Blasco-Baque V; Sérino M; Amar J
    Med Sci (Paris); 2013; 29(8-9):800-6. PubMed ID: 24005637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metagenome and metabolism: the tissue microbiota hypothesis.
    Burcelin R; Serino M; Chabo C; Garidou L; Pomié C; Courtney M; Amar J; Bouloumié A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():61-70. PubMed ID: 24003922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the gut microbiota on obesity and glucose homeostasis.
    Greiner T; Bäckhed F
    Trends Endocrinol Metab; 2011 Apr; 22(4):117-23. PubMed ID: 21353592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders.
    Musso G; Gambino R; Cassader M
    Curr Opin Lipidol; 2010 Feb; 21(1):76-83. PubMed ID: 19915460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microflora as a target for energy and metabolic homeostasis.
    Cani PD; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):729-34. PubMed ID: 18089955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.
    Natividad JM; Verdu EF
    Pharmacol Res; 2013 Mar; 69(1):42-51. PubMed ID: 23089410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota is a plastic factor responding to environmental changes.
    Candela M; Biagi E; Maccaferri S; Turroni S; Brigidi P
    Trends Microbiol; 2012 Aug; 20(8):385-91. PubMed ID: 22672911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intestinal microbiota, obesity and insulin resistance].
    Pernet A; Petriccioli N
    Rev Med Suisse; 2011 Nov; 7(317):2236-8. PubMed ID: 22400352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of metabolism: a cross talk between gut microbiota and its human host.
    Burcelin R
    Physiology (Bethesda); 2012 Oct; 27(5):300-7. PubMed ID: 23026753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interactions between intestinal microbiota and intestinal macrophages on health.
    Nakata K; Yamamoto M; Inagawa H; Soma G
    Anticancer Res; 2013 Jul; 33(7):2849-53. PubMed ID: 23780969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases.
    Burcelin R; Garidou L; Pomié C
    Semin Immunol; 2012 Feb; 24(1):67-74. PubMed ID: 22265028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and obesity.
    Scarpellini E; Campanale M; Leone D; Purchiaroni F; Vitale G; Lauritano EC; Gasbarrini A
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S53-6. PubMed ID: 20865475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.
    Cani PD; Delzenne NM; Amar J; Burcelin R
    Pathol Biol (Paris); 2008 Jul; 56(5):305-9. PubMed ID: 18178333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of intestinal microbiota in the pathogenesis of metabolic diseases.
    Węgielska I; Suliburska J
    Acta Sci Pol Technol Aliment; 2016; 15(2):201-211. PubMed ID: 28071010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The intestinal microbiota and inflammatory bowel disease].
    Guarner F
    Gastroenterol Hepatol; 2011 Mar; 34(3):147-54. PubMed ID: 21377761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.
    Musso G; Gambino R; Cassader M
    Annu Rev Med; 2011; 62():361-80. PubMed ID: 21226616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbes on-air: gut and tissue microbiota as targets in type 2 diabetes.
    Serino M; Blasco-Baque V; Burcelin R
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S27-8. PubMed ID: 22955352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microflora and metabolic diseases.
    Serino M; Luche E; Chabo C; Amar J; Burcelin R
    Diabetes Metab; 2009 Sep; 35(4):262-72. PubMed ID: 19419895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.